Pa Shun International Holdings Ltd - ESG Rating & Company Profile powered by AI
This report of Pa Shun International Holdings Ltd uses data from across the web and also from public filings by Pa Shun International Holdings Ltd. This ESG rating includes 17 UN SDGs including: 'No Poverty', 'Responsible Production & Consumption' and 'Life below Water'. Other companies in the scoring peer group for Pa Shun International Holdings Ltd are displayedin the table.
Pa Shun International Holdings Ltd in the Drug Retailers industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Sapporo Clinical Laboratory Inc | 8.0 | High |
2 | Nihon Chouzai Co Ltd | 7.5 | High |
... | ... | ... | |
68 | PharMerica Corp | 0.4 | Low |
68 | Rite Aid Corp | 0.4 | Low |
70 | Pa Shun International Holdings Ltd | 0.0 | Low |
70 | Cachet Pharmaceutical Co Ltd | 0.0 | Low |
70 | Camsing Healthcare Ltd | 0.0 | Low |
70 | Zhejiang Zhenyuan Share Co Ltd | 0.0 | Low |
70 | d1000 Varejo Farma Participacoes SA | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Pa Shun International Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Pa Shun International Holdings Ltd disclose current and historical energy intensity?
Does Pa Shun International Holdings Ltd report the average age of the workforce?
Does Pa Shun International Holdings Ltd reference operational or capital allocation in relation to climate change?
Does Pa Shun International Holdings Ltd disclose its ethnicity pay gap?
Does Pa Shun International Holdings Ltd disclose cybersecurity risks?
Does Pa Shun International Holdings Ltd offer flexible work?
Does Pa Shun International Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Pa Shun International Holdings Ltd disclose the number of employees in R&D functions?
Does Pa Shun International Holdings Ltd conduct supply chain audits?
Does Pa Shun International Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Pa Shun International Holdings Ltd conduct 360 degree staff reviews?
Does Pa Shun International Holdings Ltd disclose the individual responsible for D&I?
Does Pa Shun International Holdings Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Pa Shun International Holdings Ltd disclose current and / or historical scope 2 emissions?
Does Pa Shun International Holdings Ltd disclose water use targets?
Does Pa Shun International Holdings Ltd have careers partnerships with academic institutions?
Did Pa Shun International Holdings Ltd have a product recall in the last two years?
Does Pa Shun International Holdings Ltd disclose incidents of discrimination?
Does Pa Shun International Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Has Pa Shun International Holdings Ltd issued a profit warning in the past 24 months?
Does Pa Shun International Holdings Ltd disclose parental leave metrics?
Does Pa Shun International Holdings Ltd disclose climate scenario or pathway analysis?
Does Pa Shun International Holdings Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Pa Shun International Holdings Ltd disclose the pay ratio of women to men?
Does Pa Shun International Holdings Ltd support suppliers with sustainability related research and development?
Does Pa Shun International Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Pa Shun International Holdings Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Pa Shun International Holdings Ltd involved in embryonic stem cell research?
Does Pa Shun International Holdings Ltd disclose GHG and Air Emissions intensity?
Does Pa Shun International Holdings Ltd disclose its waste policy?
Does Pa Shun International Holdings Ltd report according to TCFD requirements?
Does Pa Shun International Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Pa Shun International Holdings Ltd disclose energy use targets?
Does Pa Shun International Holdings Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Pa Shun International Holdings Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Pa Shun International Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution activities in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Self-Operated Retail Pharmacies, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, franchise retail pharmacy chain stores, and hospitals and other medical institutions in rural areas. The Self-Operated Retail Pharmacies segment engages in the sale of pharmaceutical and healthcare products, cosmetic products, and daily necessities in self-operated retail pharmacies. The Pharmaceutical Manufacturing segment sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is based in Kwun Tong, Hong Kong. Pa Shun International Holdings Limited is a subsidiary of Praise Treasure Limited.